Physician

Janet M Schwartzenberg, MD

According to 2025 Medicare claims, Janet Schwartzenberg, MD (NPI: 1194767640) practices rheumatology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is AMARILLO MEDICAL SPECIALISTS,LLP (NPI: 1790743524; TIN: 201516910) and primary practice location at 79106-1768. Schwartzenberg is affiliated with the Texoma Clinical Partners ACO, LLC (ACO ID: A4585), Caravan Health ACO 43 LLC (ACO ID: A4974), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Schwartzenberg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,081 traditional Medicare patients, billed 279,353 HCPCS/CPT codes, and received $2,848,036 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 12,954 prescription claims across 1,172 beneficiaries totaling $4,019,569 in drug costs, led by Rinvoq (Upadacitinib). DME data shows 25 claims. Open Payments data shows 190 records totaling $5,056. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,106,606 to $2,848,036. Similarly, Part D prescription costs have risen steadily, from $1,522,551 to $4,019,569. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $16,176 to $729.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,036	98,635	$1,106,606
2016	1,044	127,485	$1,825,729
2017	1,095	140,441	$2,150,942
2018	1,306	186,268	$3,097,594
2019	1,078	196,853	$3,144,418
2020	1,086	209,346	$3,303,625
2021	1,110	243,801	$3,252,938
2022	1,086	236,759	$2,786,077
2023	1,084	279,892	$2,763,653
2024	1,081	279,353	$2,848,036

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	872	10,113	$1,522,551
2016	849	8,777	$1,398,532
2017	890	8,749	$1,703,307
2018	1,019	10,367	$2,082,802
2019	989	9,492	$2,175,763
2020	1,011	10,490	$2,517,605
2021	1,048	10,067	$2,289,324
2022	1,102	11,746	$2,626,268
2023	1,132	12,610	$3,229,130
2024	1,172	12,954	$4,019,569

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$9,671
2016	N/R	78	$6,852
2017	N/R	48	$1,725
2018	N/R	13	$57,282
2019	N/R	12	$56,999
2020	N/R	14	$73,269
2021	N/R	24	$71,573
2022	N/R	13	$73,299
2023	N/R	26	$80,015
2024	N/R	25	$80,813

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	955	2,027	$10
36415	Insertion of needle into vein for collection of blood sample	972	2,505	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	978	2,087	$7
86140	Measurement c-reactive protein for detection of infection or inflammation	975	2,042	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	990	2,117	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	149	4,950	$1,144,091
Humira(Cf) Pen	Adalimumab	54	1,850	$594,777
Enbrel Sureclick	Etanercept	47	1,428	$388,736
Xeljanz Xr	Tofacitinib Citrate	52	1,560	$303,061
Cosentyx Sensoready (2 Pens)	Secukinumab	21	588	$163,457

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$80,287
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	12	$525

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	190	$5,056	Johnson & Johnson Health Care Systems Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Janet M. Schwartzenberg, MD?

Tedicare shows public-source Medicare data for Janet M. Schwartzenberg, MD (NPI 1194767640), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Janet M. Schwartzenberg, MD have ACO affiliation data?

Janet M. Schwartzenberg, MD is shown with ACO affiliation data for Texoma Clinical Partners ACO, LLC (MSSP, ACO ID A4585), Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Janet M. Schwartzenberg, MD?

Janet M. Schwartzenberg, MD is linked to AMARILLO MEDICAL SPECIALISTS,LLP (billing NPI 1790743524) in the available physician profile data.

Does Janet M. Schwartzenberg, MD have Open Payments data?

Janet M. Schwartzenberg, MD has 190 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.